IoT (Internet Of Medical Things) To Be The Buzzword For Bile Duct Cancer Treatment Market
Cholangiocarcinoma, also known as bile duct cancer, is spreading widely in Southeast Asia, particularly in the Northeast region of Thailand. High consumption of raw fish in the Asia-Pacific (APAC) region is driving the incidence of liver fluke infections, thereby stimulating the occurrence of bile duct cancer. Increased industrialization is also attributing to the growth in the APAC bile duct cancer treatment market as exposure to harmful printing chemicals is high among industrial workers in countries such as China, Japan and India. Strategizing The Moves For The Next Decade? See Through Sample Of Bile Duct Cancer Treatment Market Report! https://www.persistencemarketresearch.com/samples/10094 Company Profiles Pfizer, Inc. F. Hoffman-La Roche AG Bristol-Myers Squibb Company Teva Pharmaceuticals Industries Ltd. Eli Lilly and Company Novartis AG Sanofi Fresenius Kabi AG Mylan N.V. Kyowa Hakko Kirin Co Ltd. Intercept Pharmaceuticals, Inc. Accord Healthc...